Phase 1 clinical update of allogeneic invariant natural killer T cells (iNKTs), agenT-797, alone or in combination with pembrolizumab or nivolumab in patients with advanced solid tumors. #CT275: AACR ProcVol 83; (8_Supplement): CT275. AACR meeting Orlando, FL, 2023.

B Carneiro, Rachel Sanborn, Dave S.B. Hoon, See all authors in notes

Research output: Contribution to conferenceAbstract

Original languageAmerican English
StatePublished - 2023

Cite this